ArticleEye (London, England)2026
Association between eye disorders and the development of ADHD/ADD: a nationwide retrospective cohort study.
Article in Eye (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
objectivesTo study and assess the association of various eye disorders with the development of attention-deficit hyperactivity disorder (ADHD/ADD).
methodsA nationwide, retrospective cohort-study, utilising anonymised electronic medical records (EMR) data on all insured individuals aged 5-30 in Maccabi Health Services (MHS), the second largest health maintenance organisation in Israel, during 2010-2022.
resultsThe final analysis included 665,121 individuals from an initial cohort of 1,686,128 after applying selection criteria and propensity score matching. Of these, 68,976 (10.4%) developed ADHD/ADD. ADHD/ADD was more common and developed faster in those with eye disorders (HR = 1.40, 95% CI: 1.38-1.42 and 4.5 versus 4.9 years, p < 0.001, respectively). All evaluated eye disorders served as significant risk factors (strabismus: HR = 1.64, 95% CI: 1.49-1.80; hyperopia: HR = 1.52, 95% CI: 1.47-1.56; astigmatism: HR = 1.52, 95% CI: 1.48-1.56; amblyopia: HR = 1.40, 95% CI: 1.27-1.54; myopia: HR = 1.30, 95% CI: 1.28-1.33). Similar findings were evident when assessing combinations of eye disorders. These associations were far more pronounced in females and the paediatric population (p < 0.001 and p = 0.044, respectively).
conclusionsEye disorders serve as risk factors for the development of ADHD/ADD, particularly in females and in the paediatric population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.